The Effect ofO6-Alkylguanine-DNA Alkyltransferase and Mismatch Repair Activities on the Sensitivity of Human Melanoma Cells to Temozolomide, 1,3-bis(2-Chloroethyl)1-nitrosourea, and Cisplatin-Reference-Cited by-同舟云学术

The Effect ofO6-Alkylguanine-DNA Alkyltransferase and Mismatch Repair Activities on the Sensitivity of Human Melanoma Cells to Temozolomide, 1,3-bis(2-Chloroethyl)1-nitrosourea, and Cisplatin

Published:2003-02-01 Issue:2 Volume:304 Page:661-668
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Pepponi Rita,Marra Giancarlo,Fuggetta Maria Pia,Falcinelli Sabrina,Pagani Elena,Bonmassar Enzo,Jiricny Josef,D'Atri Stefania

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference39 articles.

1. Resistance to cisplatin.;Akiyama;Anticancer Drug Des,1999

2. Quenching of DNA cross-link precursors of chloroethylnitrosoureas and attenuation of DNA interstrand cross-linking by glutathione.;Ali-Osman;Cancer Res,1989

3. Mammalian 3-methyladenine DNA glycosilase protects against the toxicity and clastogenicity of certain chemotherapeutic DNA cross-linking agents.;Allan;Cancer Res,1998

4. High-Frequency Microsatellite Instability is Associated with Defective DNA Mismatch Repair in Human Melanoma

5. CCNU sensitivity in mismatch repair defective human cells.;Aquilina;Cancer Res,1998

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. African medicinal plants and their constituents can fight glioblastoma and its drug resistance;Advances in Botanical Research;2024

2. Novel Imidazotetrazine Evades Known Resistance Mechanisms and Is Effective against Temozolomide-Resistant Brain Cancer in Cell Culture;ACS Chemical Biology;2022-02-04

3. Molecular Mechanisms of Drug Resistance in Glioblastoma;International Journal of Molecular Sciences;2021-06-15

4. The Role of Mismatch Repair in Glioblastoma Multiforme Treatment Response and Resistance;Neurosurgery Clinics of North America;2021-04

5. Durable Near-Complete Response to Olaparib Plus Temozolomide and Radiation in a Patient With ATM-Mutated Glioblastoma and MSH6-Deficient Lynch Syndrome;JCO Precision Oncology;2020-11